John Wright, MD
Obstetrics & Gynecology · East Liverpool, OHNPI 1295735215
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $815 of the $915 with a category attached, or 89.1%. It is spread thinly across 11 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $403 and has fallen 75.7% since, to $98 in 2025.
Across 14 payments — averaging $65.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$173
- Johnson & Johnson$170
- Novo Nordisk$120
- Astellas Pharma US Inc$100
- Phathom Pharmaceuticals, Inc.$98
- Acadia Pharmaceuticals Inc$98
- plus $157 from 5 others
What the payments were for
- Food & beverage$81589%
- Education$10011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 2 | $173 |
| Johnson & Johnson | 2 | $170 |
| Novo Nordisk | 2 | $120 |
| Astellas Pharma US Inc | 1 | $100 |
| Phathom Pharmaceuticals, Inc. | 1 | $98 |
| Acadia Pharmaceuticals Inc | 1 | $98 |
| Amgen | 1 | $97 |
| Bayer | 1 | $17 |
| Exeltis, USA Inc. | 1 | $16 |
| Pfizer | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $13 |
How this compares
$915 in reported general payments places this provider in the 60th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Risedronate Sodium | 13 | $799 |
| Ketoconazole | 17 | $361 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in East Liverpool
- Samir AhujaMentor$430K
- Burton BrodskySylvania$202K
- Sandor MecsSteubenville$190K
- David SchwartzCincinnati$169K
- Erin OlahColumbus$97K
- David PortmanColumbus$94K
- Anita SomaniColumbus$93K
- Lorie Thomas-SchultzFindlay$92K
- Oluwatosin GojeCleveland$81K
- Gerard ReillyCincinnati$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.